![](/sites/default/files/2019-04/120317_3_62.jpg)
Translational Research Institute
Clinical Trials
NCT03574597
SELECT: Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
Semaglutide is a medicine doctors can prescribe in some countries for the treatment of type 2 diabetes. A completed study showed that semaglutide reduced the risk of cardiovascular events (e.g. heart attack and stroke) in patie ...